UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

Filed by the Registrant ☒

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to §240.14a-12

 

Mind Medicine (MindMed) Inc.

(Name of Registrant as Specified In Its Charter)

N/A

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

On May 22, 2023, Mind Medicine (MindMed) Inc. (the “Company”) distributed a letter to shareholders and made postings to Reddit, Twitter and LinkedIn in connection with the Company’s 2023 Annual General Meeting of Shareholders. Copies of the letter and postings can be found below.

 

Letter to Shareholders

 

img97636535_0.jpg 

 

 

 

 


 

img97636535_1.jpg

 


 

img97636535_2.jpg 

 

 


 

img97636535_3.jpg 

 

 


 

img97636535_4.jpg 

 

 


 

img97636535_5.jpg 

 

____________________________________________________________________________________________________________

 

 

 


 

Reddit

img97636535_6.jpg 

 

 

 


 

img97636535_7.jpg 

 

 

 


 

LinkedIn

img97636535_8.jpg 

 

 

 


 

Twitter

 

img97636535_9.jpg